Why do NAD+ levels decline in aging?
12:39
Why do NAD+ levels decline in aging?
視聴回数: 1.6万 回2020年11月21日
YouTubeThe Sheekey Science Show
The Third Way to Boost NAD+
7:01
The Third Way to Boost NAD+
視聴回数: 2万 回8 か月前
YouTubeNutritionFacts.org
Targeting CD38 in Antibody-Mediated Rejection
1:03:13
Targeting CD38 in Antibody-Mediated Rejection
視聴回数: 269 回10 か月前
YouTubeAlberta Transplant Institute
SARCLISA (isatuximab) has a new delivery method tested in clinical trials. Faster, easier treatment
0:59
SARCLISA (isatuximab) has a new delivery method tested in clinical tria…
視聴回数: 820 回4 か月前
YouTubeInternational Myeloma Foundation
The iMMunoPET trial: 89Zr-DFO-daratumumab for CD38-targeted imaging of multiple myeloma
4:45
The iMMunoPET trial: 89Zr-DFO-daratumumab for CD38-targeted ima…
視聴回数: 74 回3 週間前
YouTubeVJHemOnc – Video Journal of Hematology & H…
Clinical trial updates in myeloma: anti-CD38 mAbs, ADCs, treating smoldering myeloma & more
14:14
Clinical trial updates in myeloma: anti-CD38 mAbs, ADCs, treating smolderi…
視聴回数: 452 回8 か月前
YouTubeVJHemOnc – Video Journal of Hematology & H…
Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies? | Meletios Dimopoulos, MD | #ASH25
1:56
Can Linvoseltamab Be Safely Combined with Anti-CD38 Antibodies…
視聴回数: 132 回3 週間前
YouTubeHealthTree University for Multiple Myeloma
4:28
Optimizing anti-CD38 monoclonal antibody-based quadruplet therapies …
視聴回数: 133 回9 か月前
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:08
Can anti-CD38 therapies be retained in treatment rotations for myeloma foll…
視聴回数: 43 回5 か月前
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:05
Anti-CD38–based quadruplet regimens for patients with transplan…
視聴回数: 44 回3 か月前
YouTubeVJHemOnc – Video Journal of Hematology & H…
その他のビデオを表示する
静的サムネイルプレースホルダー